What are the CDC recommendations for pharmacologic intervention in the management of Duchenne muscular dystrophy (DMD)?

Updated: Aug 17, 2020
  • Author: Twee T Do, MD; Chief Editor: Jeffrey D Thomson, MD  more...
  • Print

Pharmacologic intervention recommendations include the following:

  • Selective serotonin reuptake inhibitors (SSRIs) for depression, anxiety, obsessive-compulsive disorder
  • Mood stabilizers for aggression, anger/emotional dysregulation
  • Stimulants for attention deficit/hyperactivity disorder

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!